Patient’s experience of telemedicine during COVID-19 pandemic in a tertiary care centre in North India: a telephonic survey

Author:

Gupta Amit Kumar,Paul Sourabh,Soni Annanya,Kumar Pramod,Nath Banashree,Jotdar Arijit

Abstract

Background: Unprecedented situation of COVID-19 pandemic and measures to contain spread of the disease has expanded the horizon of health care delivery utilizing the telemedicine into the clinical practice. To understand the patients’ preferences for future incorporation of telemedicine practice into the health care system, we conducted a survey via telephone/WhatsApp.Methods: A structured survey questionnaire was administered via telephone/WhatsApp to patients attending telemedicine consultation.Results: Total 463 patients participated in the survey. Participants having favorable attitude was 237 (51.3%) and not in favors were 225 (48.7%). Among the respondents, the most common reason to choose Telemedicine was due to COVID 19 risk (70%), whereas monetary benefits were reported by only 2% of respondents. 297 respondents were of the opinion that they will continue to use tele-consultation services even after the pandemic.Conclusions: Patients reported satisfactory response using telemedicine during COVID-19 pandemic, but felt the need of physical examination at least during first consultation. Telemedicine may be suitable for screening, medium-term and long -term follow up. Easy and cheap availability of internet is also an issue particularly in low income and rural population.

Publisher

Medip Academy

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3